Sophia Genetics raised €10M in a Series B round in Jul 2014. The company is based in Saint-Sulpice, Switzerland. Investors in the round: Endeavour Vision, Invoke Capital, Swisscom. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
